Institution
UCSI University
Education•Kuala Lumpur, Malaysia•
About: UCSI University is a education organization based out in Kuala Lumpur, Malaysia. It is known for research contribution in the topics: Computer science & Population. The organization has 1200 authors who have published 1415 publications receiving 20809 citations.
Topics: Computer science, Population, DPPH, Kenaf, Adsorption
Papers published on a yearly basis
Papers
More filters
National University of Ireland, Galway1, Population Health Research Institute2, St. John's Medical College3, Eduardo Mondlane University4, Glasgow Royal Infirmary5, Sahlgrenska University Hospital6, University of Western Australia7, University of the Philippines8, Mulago Hospital9, University Hospital Bonn10, Aga Khan University11, UCSI University12, Universiti Teknologi MARA13, Dubai Health Authority14, Istanbul Medeniyet University15, University of La Frontera16, University College Hospital, Ibadan17, University of Copenhagen18, Cayetano Heredia University19, University of Split20, Rush University Medical Center21, King Saud University22, University of Limpopo23, Mahidol University24
TL;DR: The importance of potentially modifiable risk factors for stroke in different regions of the world, and in key populations and primary pathological subtypes of stroke, was quantified.
1,313 citations
Population Health Research Institute1, Hamilton Health Sciences2, University of São Paulo3, University of La Frontera4, Dubai Health Authority5, University of Gothenburg6, Isfahan University of Medical Sciences7, Independence University8, St. John's Medical College9, Aga Khan University10, Simon Fraser University11, Istanbul Medeniyet University12, UCSI University13, Universiti Teknologi MARA14, University of Wrocław15, University of Zimbabwe16, University of the Western Cape17, Peking Union Medical College18
TL;DR: This study suggests that measurement of grip strength is a simple, inexpensive risk-stratifying method for all-cause death, cardiovascular death, and cardiovascular disease.
1,184 citations
TL;DR: The economic potential assessment of microalgae biorefinery was evaluated and high-value co-products produced through the extraction of a fraction of algae were evaluated to highlight the feasibility of the process.
910 citations
Population Health Research Institute1, Oregon State University2, University of British Columbia3, University of Ottawa4, King Saud University5, University of the Philippines6, University of La Frontera7, Istanbul Medeniyet University8, North-West University9, UCSI University10, Universiti Teknologi MARA11, St. John's Medical College12, College of Health Sciences, Bahrain13, Queen's University14, Isfahan University of Medical Sciences15, Dubai Health Authority16, Birzeit University17, Independence University18, Wrocław Medical University19, Aga Khan University20, Cardiovascular Institute of the South21, Sahlgrenska University Hospital22, Post Graduate Institute of Medical Education and Research23, Simon Fraser University24, National University of Ireland, Galway25, University of London26, Laval University27
TL;DR: The prevalence, hazard ratios, and population-attributable fractions (PAFs) for cardiovascular disease and mortality associated with a cluster of behavioural factors, metabolic factors, socioeconomic and psychosocial factors, and household and ambient pollution are described.
772 citations
McMaster University1, Université du Québec2, St. John's University3, University of the Philippines Manila4, Semmelweis University5, University of Cape Town6, Centra7, Uppsala University8, UCSI University9, Technion – Israel Institute of Technology10, University of Leicester11, Alfred Hospital12, Curtin University13, University of Quindío14, Cardiovascular Institute of the South15
TL;DR: Treatment with rosuvastatin at a dose of 10 mg per day resulted in a significantly lower risk of cardiovascular events than placebo in an intermediate-risk, ethnically diverse population without cardiovascular disease.
Abstract: BackgroundPrevious trials have shown that the use of statins to lower cholesterol reduces the risk of cardiovascular events among persons without cardiovascular disease. Those trials have involved persons with elevated lipid levels or inflammatory markers and involved mainly white persons. It is unclear whether the benefits of statins can be extended to an intermediate-risk, ethnically diverse population without cardiovascular disease. MethodsIn one comparison from a 2-by-2 factorial trial, we randomly assigned 12,705 participants in 21 countries who did not have cardiovascular disease and were at intermediate risk to receive rosuvastatin at a dose of 10 mg per day or placebo. The first coprimary outcome was the composite of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke, and the second coprimary outcome additionally included revascularization, heart failure, and resuscitated cardiac arrest. The median follow-up was 5.6 years. ResultsThe overall mean low-density lipop...
640 citations
Authors
Showing all 1253 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Rahman Saidur | 97 | 576 | 34409 |
| Keng-Boon Ooi | 59 | 155 | 9398 |
| Kok-Gan Chan | 52 | 437 | 10038 |
| Khalid Yusoff | 44 | 122 | 13911 |
| Stephen Buckman | 40 | 259 | 5811 |
| Nabisab Mujawar Mubarak | 40 | 206 | 4801 |
| Kuan Yew Wong | 39 | 187 | 6756 |
| Ali Akbar Zinatizadeh | 38 | 176 | 5863 |
| Siew-Moi Phang | 36 | 240 | 6236 |
| Gangan Prathap | 30 | 241 | 3466 |
| Zaheer-Ud-Din Babar | 29 | 247 | 2942 |
| Barkawi Sahari | 29 | 124 | 2364 |
| Mohd Azlan Hussain | 27 | 137 | 3635 |
| Garry Wei-Han Tan | 27 | 54 | 2968 |
| Kar Lin Nyam | 24 | 91 | 1869 |